Assessment of Cardiac Iron Deposition in Sickle Cell Disease Using 3.0 Tesla Cardiovascular Magnetic Resonance

Many patients with sickle cell disease receive blood transfusions as a life-saving treatment. However, excess transfusions may lead to increased body iron burden. Specifically, heart failure due to cardiac iron overload is the leading cause of death in these patients. The purpose of this study was to investigate the potential role of high-field 3.0-Tesla (T) cardiovascular magnetic resonance (CMR) for assessment of cardiac iron content by measuring the transverse relaxivity rate R2*. The R2* was measured in calibrated phantoms with different iron concentrations at 3.0T and 1.5T using optimized pulse sequences. Myocardial R2* was measured at 3.0T in a group of sickle cell disease patients with different disease stages, and the results were compared to the serum ferritin levels and hepatic R2*. The phantom R2* measurements at 3.0T were double those at 1.5T, and the measurements of both systems showed linear relationships with iron concentration. The 3.0T R2* was more sensitive than 1.5T in detecting low iron concentration. In patients, myocardial R2* had weak and good correlations with hepatic R2* and serum ferritin levels, respectively. Bland-Altman analysis showed low inter- and intra-observer variabilities. In conclusion, measuring myocardial R2* at 3.0T is a promising technique with high sensitivity and reproducibility for evaluating cardiac iron overload in sickle cell disease patients.

[1]  D. Pennell,et al.  Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy , 2007, Journal of magnetic resonance imaging : JMRI.

[2]  H. Bunn.  Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.

[3]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[4]  O. Simonetti,et al.  Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease , 2007 .

[5]  P. Vaitkevicius,et al.  Quantification of Myocardial Iron Overload by Cardiovascular Magnetic Resonance Imaging T2* and Review of the Literature , 2009, Clinical cardiology.

[6]  R. Fischer,et al.  Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases. , 2000, Transfusion science.

[7]  K. Quirolo,et al.  Current issues in blood transfusion for sickle cell disease. , 2009, Current opinion in pediatrics.

[8]  P. Storey,et al.  R2* imaging of transfusional iron burden at 3T and comparison with 1.5T , 2007, Journal of magnetic resonance imaging : JMRI.

[9]  D. L. Johnston,et al.  Assessment of tissue iron overload by nuclear magnetic resonance imaging. , 1989, The American journal of medicine.

[10]  John C Wood,et al.  Magnetic Resonance Imaging Assessment of Excess Iron in Thalassemia, Sickle Cell Disease and Other Iron Overload Diseases , 2008, Hemoglobin.

[11]  P Mazza,et al.  Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. , 1995, Haematologica.

[12]  E. Eracleous,et al.  Uses and Limitations of Serum Ferritin, Magnetic Resonance Imaging T2 and T2* in the Diagnosis of Iron Overload and in the Ferrikinetics of Normalization of the Iron Stores in Thalassemia Using the International Committee on Chelation Deferiprone/Deferoxamine Combination Protocol , 2009, Hemoglobin.

[13]  S. Jasko,et al.  Therapy , 1881, The American journal of dental science.

[14]  V. Anttila,et al.  Magnetic resonance imaging of transfusional hepatic iron overload. , 1994, The British journal of radiology.

[15]  B. Gerber,et al.  Iron overload in polytransfused patients without heart failure is associated with subclinical alterations of systolic left ventricular function using cardiovascular magnetic resonance tagging , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[16]  C. Hillenbrand,et al.  R2* magnetic resonance imaging of the liver in patients with iron overload. , 2009, Blood.

[17]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[18]  D. Pennell.  T2* Magnetic Resonance and Myocardial Iron in Thalassemia , 2005, Annals of the New York Academy of Sciences.

[19]  Greg Brown,et al.  Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion‐dependent patients with β thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events , 2010, Internal medicine journal.

[20]  R. Parkkola,et al.  Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. , 2008, Magnetic resonance imaging.

[21]  P. Harmatz,et al.  Severity of Iron Overload in Patients with Sickle Cell Disease Receiving Chronic Red Blood Cell Transfusion Therapy , 2000, Blood.

[22]  W. Frey,et al.  Quantitative measurement of liver iron by needle biopsy. , 1968, The Journal of laboratory and clinical medicine.

[23]  M. Francone,et al.  Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias. , 2011, European journal of internal medicine.

[24]  E. Eracleous,et al.  Low Serum Ferritin Levels are Misleading for Detecting Cardiac Iron Overload and Increase the Risk of Cardiomyopathy in Thalassemia Patients. The Importance of Cardiac Iron Overload Monitoring Using Magnetic Resonance Imaging T2 and T2* , 2006, Hemoglobin.

[25]  G. McLaren,et al.  Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. , 1983, Critical reviews in clinical laboratory sciences.

[26]  M. Harada,et al.  Comparative study of magnetic resonance imaging, computed tomography and histology in the assessment of liver iron overload. , 1992, Internal medicine.

[27]  J. Porter.  Concepts and goals in the management of transfusional iron overload , 2007, American journal of hematology.

[28]  D. Vartsky,et al.  Nuclear resonant scattering of gamma rays--a new technique for in vivo measurement of body iron stores. , 1979, Physics in medicine and biology.

[29]  Ioannis Seimenis,et al.  R2 relaxometry with MRI for the quantification of tissue iron overload in β‐thalassemic patients , 2006, Journal of magnetic resonance imaging : JMRI.

[30]  Marvin D Nelson,et al.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. , 2004, Blood.

[31]  I. Papassotiriou,et al.  Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease , 2004, British journal of haematology.

[32]  T G Maris,et al.  Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. , 1995, Magnetic resonance imaging.

[33]  D. Halperin,et al.  Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. , 1993, Chest.

[34]  R. Muthupillai,et al.  Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging. , 2005, Texas Heart Institute journal.

[35]  T. Coates,et al.  Improved R2* measurements in myocardial iron overload , 2006, Journal of magnetic resonance imaging : JMRI.

[36]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[37]  John C Wood,et al.  Magnetic resonance imaging measurement of iron overload , 2007, Current opinion in hematology.

[38]  W. Henry,et al.  Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. , 1978, The American journal of medicine.

[39]  Emanuele Angelucci,et al.  Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias , 2008, Haematologica.

[40]  S. Mavrogeni.  Evaluation of myocardial iron overload using magnetic resonance imaging. , 2009, Blood transfusion = Trasfusione del sangue.

[41]  D. Tsiapras,et al.  A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β‐thalassemia major , 2005, European journal of haematology.